The role of the Investor Relations Department is to maintain a transparent and comprehensive dialogue with the financial community about Sanofi's strategy, outlook and financial data, its economic environment and any other useful information.
For general inquiries
Please contact the switchboard, +33 (0)1 53 77 40 00
To contact the Investors Relations team
Mail: investor.relations@sanofi.com
Thomas Kudsk Larsen
Head of Investor Relations
Global
+44 7545 513 693
Nathalie Pham
Investor Relations Officer
Vaccines, Opella, Rare diseases
Europe
+33 7 85 93 30 17
Alizé Kaisserian
Investor Relations Officer
Pipeline (all), Neurology, Oncology
Europe
+33 6 47 04 12 11
Thibaud Chatelet
Investor Relations Officer
Finance, ESG
Europe
+33 6 80 80 89 90
Yun Li
Investor Relations Officer
ESG, Finance, Neurology, Oncology
Europe
+33 6 84 00 90 72
Marie Lang
Investor Relations Manager
Corporate access
Europe
+33 6 70 83 59 31
Aline Communeau
Investor Relations Coordinator
Private shareholders
Europe
+33 6 98 90 45 15
Felix Lauscher
Head of Investor Relations
General medicines
North America & Asia
+1 908 612 7239
Tarik Elgoutni
Investor Relations Officer
Immunology
North America
+1 617 528 8427
Keita Browne
Investor Relations Officer
Rare diseases, finance
North America
+1 617 685 6662
Caroline Kuriata
Investor Relations Analyst
Corporate access, US
North America
+1 908 981 6401